Malta vs Oman: Previously treated cases tested for RR-/MDR-TB
Malta
100.0%
in 2022
Oman
100.0%
in 2024
Malta rank
1st
Oman rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Malta
- Oman
How they compare
Malta currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
Across all 8 years both countries report, Oman has been ahead every year.
Malta ranks 1st and Oman ranks 1st of 180 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malta | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.3% | 100.0% | 85.7% | Oman |
| 2010s | 66.8% | 97.2% | 30.5% | Oman |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Malta or Oman?
- Malta, at 100.0% against 100.0% in Oman as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Malta and Oman?
- 0.0%, with Malta ahead.
- How many years of comparable data are there for Malta and Oman?
- 8 years are reported by both, from 2007 to 2022.
- How do Malta and Oman rank globally for previously treated cases tested for rr-/mdr-tb?
- Malta ranks 1st and Oman ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.